28 / 1631
Ensure that the unique biology of lymphoid malignancies is
exploited in RT planning and delivery
In general no survival advantage has been demonstrated with the extended fields
of the past
The unique radiosensitivity of lymphoid malignancies means that dose
constraints for normal tissues used for solid tumours are not applicable
Modern conformal techniques should be used for lymphomas, not primarily as in
solid tumours to allow a high target dose to be delivered, but to minimize the
risk of long-term complications
Different techniques are applicable to different disease localizations and disease
volumes, no two patients are the same